Key Highlights

  • NIVF shares are trading 1.74% lower at $1.13 on Wednesday, October 28, 2026.
  • Short interest was 308,799 shares for the October 15 settlement date, up from 2,189 on September 30.
  • That position equals about 27.7% of the 1.12 million shares outstanding, with days to cover of 1.00.
  • The six months to June 30, 2026 produced a net loss of $8.04 million on revenue of $1.92 million.
  • The company values its expected K25.ai stake at about $26 million, against a market value near $1.28 million.

NewGenIvf Short Interest: Why Did Bearish Positions Appear So Suddenly?

NewGenIvf Group (NASDAQ:NIVF) shares are trading 1.74% lower at $1.13 on Wednesday, October 28, 2026, which implies a prior close near $1.15 (calculated). No company announcement dated October 28 accompanies the move. The stock features among the most shorted names after short interest jumped for the October 15 settlement date.

Short-interest data for the settlement date of October 15, 2026 show 308,799 shares sold short, up by 306,610 from 2,189 at September 30. Positions had been in the hundreds to low thousands of shares for months. The figure equals about 27.7% of 1.12 million shares outstanding (shares outstanding are not the same as free float), and days to cover were 1.00 on average daily volume near 4.1 million shares.

NewGenIvf Group operates fertility-related businesses and holds technology investments, including a stake in K25.ai. Its market value is about $1.28 million at the screen price.

What a Crowded Short Could Mean for a Stock With a 1.12 Million Share Count

A short position this large relative to the share count can magnify moves in both directions. Covering purchases can lift the price quickly, while continued selling can deepen declines, and daily volume far above the share count means small orders can swing the price.

The sources do not state the reason for the small share count. The September offering covered 17,857,143 shares or pre-funded warrants at $0.07 each, so a share consolidation since then appears likely, although no ratio is given. The next short-interest figure, for the October 30 settlement date, is expected on November 10.

Half-Year Loss Versus the K25.ai Stake: Which Number Matters More?

A filing dated October 27 reported a net loss attributable to shareholders of $8,035,306 for the six months ended June 30, 2026, compared with a profit of $724,975 a year earlier. Revenue fell to $1,924,881 and gross margin was 24.1%. For the year ended December 31, 2025 the company had reported net profit of $9.9 million and net assets of about $25.98 million.

The company holds 10% of K25.ai at a valuation of $100 million. On July 27 it agreed to buy a further 3% for $7.5 million at a $250 million valuation, and on July 30 it said the expected 13% stake is worth about $26 million, an unrealised gain of about $8.5 million. That valuation depends on completion and on K25.ai's own pricing.

Financing remains frequent. A public offering priced on September 28 closed on September 30 for gross proceeds of about $1.25 million. The company also exchanged convertible notes on August 14 and has operated under a forbearance agreement dated June 16.

What to Watch Next: November 10 Short Data and the K25.ai Completion

The October 30 short-interest figure, due on November 10, will show whether the position was cut or built. Investors will also watch completion of the additional K25.ai purchase, any further capital raise and Nasdaq compliance notices tied to the company's small market value.